Pleural-effusion detection sensitivity
97 percent
- EndpointFinding detection sensitivity
- PopulationLung ultrasound scans in the FDA bench dataset
- Tested versionLung AI LAI001
FDA-cleared profile
Exo Inc · Ultrasound · FDA-cleared (510(k))
Authorized purpose: Lung AI LAI001 assists trained healthcare professionals performing point-of-care lung ultrasound by detecting and visualizing pleural effusion and consolidation or atelectasis in lung ultrasound cine clips.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Lung AI LAI001 assists trained healthcare professionals performing point-of-care lung ultrasound by detecting and visualizing pleural effusion and consolidation or atelectasis in lung ultrasound cine clips.
Evidence takeaway. Evidence from the reviewed source record: K243239 FDA decision material reports the exact evidence metrics included below for Lung AI LAI001; values are limited to the stated endpoint, population, and operating point.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
97 percent
91 percent
97 percent
94 percent
K243239
FDA-reported detection results for the exact LAI001 configuration; reader-aided results are not generalized here.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
No exact-product reimbursement determination identified in reviewed public material
Centers for Medicare & Medicaid Services · United StatesThis public-policy review is not a coverage determination. Verify payer, site-of-service, coding, and local value assumptions independently.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Lung ultrasound cine clips acquired during the BLUE protocol PLAPS point.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-04 · FDA 510(k) decision material K243239: Lung AI (LAI001)
Source context, not route validation: The FDA package describes post-processing integrated by a programmer into a third-party ultrasound device and displayed in the existing ultrasound interface without a built-in viewer.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-04 · FDA 510(k) decision material K243239: Lung AI (LAI001)
Source context, not route validation: The FDA package describes integration into a third-party ultrasound device; current device configuration, hosting, security, availability, and service boundaries remain unknown.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-04 · FDA 510(k) decision material K243239: Lung AI (LAI001)
Source context, not route validation: One region of interest per clip frame showing the largest detected finding for visualization; no patient-level aggregation is provided.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-04 · FDA 510(k) decision material K243239: Lung AI (LAI001)
Unresolved route: One region of interest per clip frame showing the largest detected finding for visualization; no patient-level aggregation is provided.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-04 · FDA 510(k) decision material K243239: Lung AI (LAI001)
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Vendor statement, not an attestation; exact-release scope is not established.
Map installed build, options, population, anatomy, inputs, outputs, and enabled functions to K243239.
exact submission · checked 2026-09-04The FDA package describes integration into a third-party ultrasound device; current device configuration, hosting, security, availability, and service boundaries remain unknown.
exact submission · checked 2026-09-04The FDA package describes post-processing integrated by a programmer into a third-party ultrasound device and displayed in the existing ultrasound interface without a built-in viewer.
exact submission · checked 2026-09-04Test labeled population, acquisition quality, exclusions, failed inputs, reviewer overrides, and downstream effects for K243239.
exact submission · checked 2026-09-04Exact-product price, implementation cost, reimbursement, and total-cost evidence remain to be obtained; do not infer them from FDA clearance.
product family · checked 2026-09-04Monitor labeling, software version, complaints, recalls, failed inputs, overrides, and postmarket signals against the exact submission and installed configuration.
exact submission · checked 2026-09-04Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
No evidence was promoted. All records concern unrelated cancer, CT, animal, or lung-ultrasound products from other vendors and do not identify Exo Lung AI LAI001 or K243239. The current discovery snapshot contains 6 PubMed and 3 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public list price or commercial contract for the exact submission and version was identified.
No exact-product payer coverage or reimbursement determination was identified in reviewed public material.
8 sources - 3 history items
Scope: identity, submission_linkage, modality, anatomy, clinical_use, intended_users, care_setting, workflow_role, input, output, limitations, evidence
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: coverage, codingContext
Scope: recallDiscovery, nativeSubmissionMatching
Scope: security
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Smart Alfa Teknoloji San. Ve Tic. A.S.
Authorized purpose: Assist qualified MSK-ultrasound professionals by highlighting supported joint anatomy and detection completeness on compatible adult ultrasound images; it is not a diagnostic device.
Sonio
Authorized purpose: Sonio Detect v3 analyzes fetal ultrasound images and clips to detect views and anatomical structures and to check labeled image-quality characteristics during acquisition or interpretation.
Bioticsai, Inc.
Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.
Brightheart
Authorized purpose: Concurrent CADx aid for suspicious fetal cardiac morphological findings during second-trimester fetal heart ultrasound.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history